Katy Ticona in Brandon, Florida

Home Florida Brandon

Katy Ticona has Hematology/oncology as her primary medical specialty. Their primary office is: 500 Vonderburg Dr in Brandon, Florida.

They're a part of the: The Oncology Institute Fl, Llc medical group which has around 12 members. You can call their office at 813-681-7278 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2013 (around 11 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Katy Ticona Office Phone and Directions

Katy Ticona
The Oncology Institute Fl, Llc
500 Vonderburg Dr
Brandon, Florida 33511
813-681-7278

Patient Ratings
Please rate your experience with Katy Ticona below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 813-681-7278

Enter a starting address:

Healthcare Info for Katy Ticona

Medical School: Sorry, her university is not listed
Graduation Year: 2013
The Primary Medical Specialty for Katy Ticona is listed as: Hematology/oncology
Approximate Years of Experience: 11
PAC (PECOS ID)#: 7113264656
NPI #: 1669867966
NPI Created On: 04/02/2015
NPI Last Updated Listed as: 01/11/2021
Primary Taxonomy Code: 390200000X
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
Initial hospital inpatient care, typically 50 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 820303859

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: NINLARO

Open Associated Drug #1: 63020-078-02